Gdje sam? Skip Navigation Links Vijesti i arhiva

Novosti News

19.8.2021. 11:29
vakcina
 

Pfizer COVID vaccine 86% effective after third shot - Maccabi

The data was based on a follow-up study carried out by the fund’s Division of Data & Digital Health of people who received their third dose at least seven days ago. 

By MAAYAN JAFFE-HOFFMAN   AUGUST 18, 2021 2

 Prevodimo članak

The Pfizer coronavirus vaccine has been shown to be 86% effective in preventing infection among those ages 60 and older after a third dose, according to initial results published Wednesday by Maccabi Health Services.
“The vaccine has again proved its effectiveness,” said Dr. Anat Ekka Zohar, who led the study. “It has also demonstrated protection against the Delta variant. The triple dose is the solution to curbing the current outbreak.”

Pfizer vakcina se pokazala  efektivnom u 86% u prevenciji infekcije kod osoba starijih od 60 godina nakon primanja treće doze. To su rezultati publicirani u srijedu od strane Maccabi Health servisa. 

Dr- Anai Ekka Zophar koji vodi studio je kazao da se vakcina ponovno pokazala efikasnom i u zaštiti od Delta varijante virusa. trostruka doza je rješenje da se spriječi sadašnje širenje virusa. 

dalje čitajte u originalnom članku:

“Three-dose vaccine effectiveness is highly protective against both infection and severe illness,” Ekka Zohar concluded. “I urge everyone aged 50 and over who have yet to receive the third vaccine dose to do so, for both their self-protection and the protection of their families.”

So far, more than 1.1 million Israelis have received a third vaccination.